Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte: Tratamento agudo e de continuação do transtorno depressivo maior

Michael Bauer, Peter C. Whybrow, Jules Angst, Marcio Versiani, Hans Jürgen Möller, Hervé Allain, Ian Anderson, José L. Ayuso-Gutierrez, David Baldwin, Per Bech, Otto Benkert, Michael Berk, I. Bitter, Marc L. Bourgeois, Graham Burrows, Giovanni Cassano, Marcelo Cetkovich-Bakmans, John C. Cookson, Delcir Da Costa, Mihai D. GherogheGerardo Heinze, Teruhiko Higuchi, Robert M. Hirschfeld, Cyril Höschl, Edith Holsboer-Trachsler, Siegfried Kasper, Cornelius Katona, Martin B. Keller, Parmanand Kulhara, David J. Kupfer, Yves Lecrubier, Brian Leonard, Rasmus W. Licht, Odd Lingjaerde, Henrik Lublin, Julien Mendlewicz, Philip Mitchell, Eugene S. Paykel, Stanislaw Puzynski, A. John Rush, Janusz K. Rybakowski, Isaac Schweitzer, Jürgen Unützer, Per Verstergaard, Eduard Vieta, Kazuo Yamada, Jens Wiltfang

Research output: Article

4 Citations (Scopus)

Abstract

These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). This first part of the guidelines covers disease definition, classification, epidemiology and course of unipolar depressive disorders, as well as the management of the acute and continuation-phase treatment. These guidelines are primarily concerned with the biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy, adjunctive and novel therapeutic strategies) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.

Original languageUndefined/Unknown
Pages (from-to)17-57
Number of pages41
JournalRevista de Psiquiatria Clinica
Volume36
Issue numberSUPPL. 2
DOIs
Publication statusPublished - 2009

Fingerprint

Biological Psychiatry
Major Depressive Disorder
Depressive Disorder
Guidelines
Therapeutics
Antidepressive Agents
Electroconvulsive Therapy
Phototherapy
Advisory Committees
Practice Guidelines
MEDLINE
Libraries
Meta-Analysis
Young Adult
Epidemiology
Databases
Physicians

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte : Tratamento agudo e de continuação do transtorno depressivo maior. / Bauer, Michael; Whybrow, Peter C.; Angst, Jules; Versiani, Marcio; Möller, Hans Jürgen; Allain, Hervé; Anderson, Ian; Ayuso-Gutierrez, José L.; Baldwin, David; Bech, Per; Benkert, Otto; Berk, Michael; Bitter, I.; Bourgeois, Marc L.; Burrows, Graham; Cassano, Giovanni; Cetkovich-Bakmans, Marcelo; Cookson, John C.; Costa, Delcir Da; Gheroghe, Mihai D.; Heinze, Gerardo; Higuchi, Teruhiko; Hirschfeld, Robert M.; Höschl, Cyril; Holsboer-Trachsler, Edith; Kasper, Siegfried; Katona, Cornelius; Keller, Martin B.; Kulhara, Parmanand; Kupfer, David J.; Lecrubier, Yves; Leonard, Brian; Licht, Rasmus W.; Lingjaerde, Odd; Lublin, Henrik; Mendlewicz, Julien; Mitchell, Philip; Paykel, Eugene S.; Puzynski, Stanislaw; Rush, A. John; Rybakowski, Janusz K.; Schweitzer, Isaac; Unützer, Jürgen; Verstergaard, Per; Vieta, Eduard; Yamada, Kazuo; Wiltfang, Jens.

In: Revista de Psiquiatria Clinica, Vol. 36, No. SUPPL. 2, 2009, p. 17-57.

Research output: Article

Bauer, M, Whybrow, PC, Angst, J, Versiani, M, Möller, HJ, Allain, H, Anderson, I, Ayuso-Gutierrez, JL, Baldwin, D, Bech, P, Benkert, O, Berk, M, Bitter, I, Bourgeois, ML, Burrows, G, Cassano, G, Cetkovich-Bakmans, M, Cookson, JC, Costa, DD, Gheroghe, MD, Heinze, G, Higuchi, T, Hirschfeld, RM, Höschl, C, Holsboer-Trachsler, E, Kasper, S, Katona, C, Keller, MB, Kulhara, P, Kupfer, DJ, Lecrubier, Y, Leonard, B, Licht, RW, Lingjaerde, O, Lublin, H, Mendlewicz, J, Mitchell, P, Paykel, ES, Puzynski, S, Rush, AJ, Rybakowski, JK, Schweitzer, I, Unützer, J, Verstergaard, P, Vieta, E, Yamada, K & Wiltfang, J 2009, 'Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte: Tratamento agudo e de continuação do transtorno depressivo maior', Revista de Psiquiatria Clinica, vol. 36, no. SUPPL. 2, pp. 17-57. https://doi.org/10.1590/S0101-60832009000800001
Bauer, Michael ; Whybrow, Peter C. ; Angst, Jules ; Versiani, Marcio ; Möller, Hans Jürgen ; Allain, Hervé ; Anderson, Ian ; Ayuso-Gutierrez, José L. ; Baldwin, David ; Bech, Per ; Benkert, Otto ; Berk, Michael ; Bitter, I. ; Bourgeois, Marc L. ; Burrows, Graham ; Cassano, Giovanni ; Cetkovich-Bakmans, Marcelo ; Cookson, John C. ; Costa, Delcir Da ; Gheroghe, Mihai D. ; Heinze, Gerardo ; Higuchi, Teruhiko ; Hirschfeld, Robert M. ; Höschl, Cyril ; Holsboer-Trachsler, Edith ; Kasper, Siegfried ; Katona, Cornelius ; Keller, Martin B. ; Kulhara, Parmanand ; Kupfer, David J. ; Lecrubier, Yves ; Leonard, Brian ; Licht, Rasmus W. ; Lingjaerde, Odd ; Lublin, Henrik ; Mendlewicz, Julien ; Mitchell, Philip ; Paykel, Eugene S. ; Puzynski, Stanislaw ; Rush, A. John ; Rybakowski, Janusz K. ; Schweitzer, Isaac ; Unützer, Jürgen ; Verstergaard, Per ; Vieta, Eduard ; Yamada, Kazuo ; Wiltfang, Jens. / Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte : Tratamento agudo e de continuação do transtorno depressivo maior. In: Revista de Psiquiatria Clinica. 2009 ; Vol. 36, No. SUPPL. 2. pp. 17-57.
@article{7070390c009548aa837262a89523ab3d,
title = "Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biol{\'o}gico de transtornos depressivos unipolares, 1a parte: Tratamento agudo e de continua{\cc}{\~a}o do transtorno depressivo maior",
abstract = "These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). This first part of the guidelines covers disease definition, classification, epidemiology and course of unipolar depressive disorders, as well as the management of the acute and continuation-phase treatment. These guidelines are primarily concerned with the biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy, adjunctive and novel therapeutic strategies) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.",
keywords = "Acute treatment, Antidepressants, Biological treatment, Continuation treatment, Evidence-based guidelines, Major depressive disorder, Pharmacotherapy",
author = "Michael Bauer and Whybrow, {Peter C.} and Jules Angst and Marcio Versiani and M{\"o}ller, {Hans J{\"u}rgen} and Herv{\'e} Allain and Ian Anderson and Ayuso-Gutierrez, {Jos{\'e} L.} and David Baldwin and Per Bech and Otto Benkert and Michael Berk and I. Bitter and Bourgeois, {Marc L.} and Graham Burrows and Giovanni Cassano and Marcelo Cetkovich-Bakmans and Cookson, {John C.} and Costa, {Delcir Da} and Gheroghe, {Mihai D.} and Gerardo Heinze and Teruhiko Higuchi and Hirschfeld, {Robert M.} and Cyril H{\"o}schl and Edith Holsboer-Trachsler and Siegfried Kasper and Cornelius Katona and Keller, {Martin B.} and Parmanand Kulhara and Kupfer, {David J.} and Yves Lecrubier and Brian Leonard and Licht, {Rasmus W.} and Odd Lingjaerde and Henrik Lublin and Julien Mendlewicz and Philip Mitchell and Paykel, {Eugene S.} and Stanislaw Puzynski and Rush, {A. John} and Rybakowski, {Janusz K.} and Isaac Schweitzer and J{\"u}rgen Un{\"u}tzer and Per Verstergaard and Eduard Vieta and Kazuo Yamada and Jens Wiltfang",
year = "2009",
doi = "10.1590/S0101-60832009000800001",
language = "Undefined/Unknown",
volume = "36",
pages = "17--57",
journal = "Revista de Psiquiatria Clinica",
issn = "0101-6083",
publisher = "Lemos Editorial e Graficos Ltda",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte

T2 - Tratamento agudo e de continuação do transtorno depressivo maior

AU - Bauer, Michael

AU - Whybrow, Peter C.

AU - Angst, Jules

AU - Versiani, Marcio

AU - Möller, Hans Jürgen

AU - Allain, Hervé

AU - Anderson, Ian

AU - Ayuso-Gutierrez, José L.

AU - Baldwin, David

AU - Bech, Per

AU - Benkert, Otto

AU - Berk, Michael

AU - Bitter, I.

AU - Bourgeois, Marc L.

AU - Burrows, Graham

AU - Cassano, Giovanni

AU - Cetkovich-Bakmans, Marcelo

AU - Cookson, John C.

AU - Costa, Delcir Da

AU - Gheroghe, Mihai D.

AU - Heinze, Gerardo

AU - Higuchi, Teruhiko

AU - Hirschfeld, Robert M.

AU - Höschl, Cyril

AU - Holsboer-Trachsler, Edith

AU - Kasper, Siegfried

AU - Katona, Cornelius

AU - Keller, Martin B.

AU - Kulhara, Parmanand

AU - Kupfer, David J.

AU - Lecrubier, Yves

AU - Leonard, Brian

AU - Licht, Rasmus W.

AU - Lingjaerde, Odd

AU - Lublin, Henrik

AU - Mendlewicz, Julien

AU - Mitchell, Philip

AU - Paykel, Eugene S.

AU - Puzynski, Stanislaw

AU - Rush, A. John

AU - Rybakowski, Janusz K.

AU - Schweitzer, Isaac

AU - Unützer, Jürgen

AU - Verstergaard, Per

AU - Vieta, Eduard

AU - Yamada, Kazuo

AU - Wiltfang, Jens

PY - 2009

Y1 - 2009

N2 - These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). This first part of the guidelines covers disease definition, classification, epidemiology and course of unipolar depressive disorders, as well as the management of the acute and continuation-phase treatment. These guidelines are primarily concerned with the biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy, adjunctive and novel therapeutic strategies) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.

AB - These practice guidelines for the biological treatment of unipolar depressive disorders were developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal for developing these guidelines was to systematically review all available evidence pertaining to the treatment of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. These guidelines are intended for use by all physicians seeing and treating patients with these conditions. The data used for developing these guidelines have been extracted primarily from various national treatment guidelines and panels for depressive disorders, as well as from meta-analyses and reviews on the efficacy of antidepressant medications and other biological treatment interventions identified by a search of the MEDLINE database and Cochrane Library. The identified literature was evaluated with respect to the strength of evidence for its efficacy and was then categorized into four levels of evidence (A-D). This first part of the guidelines covers disease definition, classification, epidemiology and course of unipolar depressive disorders, as well as the management of the acute and continuation-phase treatment. These guidelines are primarily concerned with the biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy, adjunctive and novel therapeutic strategies) of young adults and also, albeit to a lesser extent, children, adolescents and older adults.

KW - Acute treatment

KW - Antidepressants

KW - Biological treatment

KW - Continuation treatment

KW - Evidence-based guidelines

KW - Major depressive disorder

KW - Pharmacotherapy

UR - http://www.scopus.com/inward/record.url?scp=77949670413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949670413&partnerID=8YFLogxK

U2 - 10.1590/S0101-60832009000800001

DO - 10.1590/S0101-60832009000800001

M3 - Article

AN - SCOPUS:77949670413

VL - 36

SP - 17

EP - 57

JO - Revista de Psiquiatria Clinica

JF - Revista de Psiquiatria Clinica

SN - 0101-6083

IS - SUPPL. 2

ER -